Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
conjugated estrogens | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Carcinoma[MeSHID:D002277] Disease[MeSHID:D004194] Osteoporosis Postmenopausal[MeSHID:D015663] Vagina[MeSHID:D014621] Neoplasm Metastasis[MeSHID:D009362] Ovarian Failure Premature[MeSHID:D016649] Malignant neoplasm of breast[MeSHID:D001943] Prostate[MeSHID:D011467] Hypogonadism[MeSHID:D007006] Atrophic[MeSHID:D001284] Vulva[MeSHID:D014844] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
conjugated estrogens | estrogen receptor beta | small molecule | Successful target | TTD , drugbank , DGIDB | Carcinoma[MeSHID:D002277] Disease[MeSHID:D004194] Osteoporosis Postmenopausal[MeSHID:D015663] Vagina[MeSHID:D014621] Neoplasm Metastasis[MeSHID:D009362] Ovarian Failure Premature[MeSHID:D016649] Malignant neoplasm of breast[MeSHID:D001943] Prostate[MeSHID:D011467] Hypogonadism[MeSHID:D007006] Atrophic[MeSHID:D001284] Vulva[MeSHID:D014844] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
click here to return to the previous page |